Navigation Links
Aventura Closes $4.3 Million in New Funding; Appoints John Gobron President and CEO
Date:9/26/2013

f healthcare IT today is the use, meaningful or otherwise, of clinical systems to help drive better outcomes. One of the torturous challenges for clinicians has always been usability of these systems. Aventura's patented awareness computing platform makes these systems incredibly more responsive for doctors and nurses. Better information access for mobile clinicians increases real-time documentation and supports important initiatives such as cost containment, meaningful use efforts, and PHI security in hospitals.

“In the age of awareness computing, clinical systems become intelligent as they draw inference from the user and patient’s needs to deliver the right information, at the right location, at the right instant, with the right workflow, for the right patient. We call this the five rights of clinical workflow,” said John Gobron, Aventura President and CEO. “This investment is a true vote of confidence in Aventura’s ability to implement intelligent systems and empower clinicians to deliver seamless, high quality care that focuses on the patient, and I’m thrilled to be a part of it.”

This financing builds on Aventura’s previously announced $13 million equity financing in 2011 and strong backing of leading venture capital investors.

About Aventura:
Aventura is the leading provider of awareness computing for the healthcare industry. For decades, clinicians have had to adapt their workflow to the limitations of computers; with Aventura, computers can now adapt to how clinicians work. Through its patented technology, Aventura delivers awareness of a user's identity and role, their location within a facility, what device they are working on, and what patient they are treating. Based on this awareness, they are able to immediately deliver a virtual desktop and dynamically provision the applications a user needs and exact screens required to care for that particular patient, eliminating wasteful clicks and keystrokes. As a result,
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Aventura Rejuvenation Announces Their Biggest Loser 30 Day Weight Loss Competition
2. New Research Discloses that Pseudotumor Formation Occurs in Close to 30% of Metal-on-Metal Hip Implants, Parker Waichman LLP Notes
3. Tinnitus Miracle Review Discloses Effective Way to Eliminate Disturbing Ear Noise
4. Total Wellness Cleanse Detox Diet Review Discloses the Secrets to Full Body Detoxification
5. 14 Day Rapid Fat Loss Plan Review Discloses Shaun Hadsall’s Effective Program
6. Truth about Cellulite Review Discloses the Secrets to Joey Atlas’ Program
7. Natural Multiple Sclerosis Treatment Review Discloses Safe Home Remedy for MS
8. Tinnitus Miracle Treatment Review Discloses New Home Remedy for Tinnitus
9. Multiple Sclerosis Treatment Review Discloses a New Way of Curing MS Naturally
10. The Kidney Disease Solution Review Discloses Effective Natural Home Remedy
11. AxoGen, Inc. Closes $18 Million Offering and Moves to NASDAQ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... VA (PRWEB) , ... September 03, 2015 , ... ... the Spouse/Caregiver Scholarship applications are open for spring 2016. Scholarships are awarded two ... members. Hope For The Warriors® is a national nonprofit dedicated to restoring a ...
(Date:9/3/2015)... ... September 03, 2015 , ... Advice columnist, professional ... her debut book, “Stop Wasting Your Time Blaming Others for Your Life.” , ... guide to overcoming life’s obstacles by taking full responsibility for one’s life shares ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... comprehensive eating disorder treatment for adults and adolescents struggling with anorexia, bulimia, ... has joined the medical treatment team. As a Staff Psychiatrist, Dr. Calinoiu ...
(Date:9/3/2015)... ... 2015 , ... As a result of the Patient Protection ... insurance plans, more employers are moving to a self-funded model for pharmacy plans, ... United Benefit Advisors (UBA) Health Plan Survey. , UBA’s survey, the nation’s largest ...
(Date:9/3/2015)... ... 03, 2015 , ... ProScrub is a set of automated tools that allow ... custom speed effects without the use of keyframes. Utilize ProScrub's powerful sliders to ... are perfect complements to energetic video productions. ProScrub is a Final Cut ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 2Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 4Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2
... , , SAN RAMON, Calif., ... who plays Dwight Schrute on NBC,s hit show The Office, ... night, August 15, at the home of Gouya and Payam Zamani, ... Mona Foundation, a non-profit organization that supports social and economic development ...
... juice to combat urinary tract infections is ,unsatisfactory and ... day..." Not all medical problems require a state-of-the-art solution, ... from the corner shop could treat a widespread and ... touted as a simple solution for urinary tract infections, ...
... , , , ... a leading national law firm in the fight against mesothelioma and ... foremost trial attorneys in the country, has joined the firm as ... of asbestos cancer cases since the late 1970s. He has successfully ...
... , , , ... sanofi-aventis U.S. announced today that the U.S. Food and Drug ... six months and older for the relief of symptoms of ... hives) and for children age two years and older for ...
... Avacor ( ) P r oducts LLC ... in the hair re-growth industry, has recently teamed up with two charitable organizations, ... ), and Team Continuum ( http://www.teamcontinuum.net ). ... fighting cancer as well as to help find new ways to fight this prolific ...
... , ST. LOUIS, Aug. 24 ... the herbicide Atrazine have attorney and clean water advocate Steve ... transparency and accountability for the herbicide,s manufacturers. , , ... in the New York Times and the Peoria Journal Star ...
Cached Medicine News:Health News:Rainn Wilson ('Dwight' on The Office) Joins Reply.com at Fundraiser for Mona Foundation 2Health News:Decorated Trial Attorney Conard Metcalf Joins Simmons Firm as 'Of Counsel' 2Health News:Decorated Trial Attorney Conard Metcalf Joins Simmons Firm as 'Of Counsel' 3Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 2Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 3Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 4Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 5Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 6Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 7Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 8Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 9Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 10Health News:Avacor(R), a Leader in Hair Regrowth, Announces Charities of Choice: Team Continuum and City of Hope 2Health News:Korein Tillery: Is Time Running Out for the Manufacturers of the Herbicide Atrazine? 2Health News:Korein Tillery: Is Time Running Out for the Manufacturers of the Herbicide Atrazine? 3
(Date:9/3/2015)... 2015  The findings of a year-long investigation conducted ... the company,s handling of its Recovery IVC filter ... nd , part one of the series ... least 27 fatalities, have been associated with the Recovery ... by C.R. Bard in 2004 which linked the Recovery ...
(Date:9/3/2015)... , Sept. 3, 2015 Research and Markets ... "Investigation Report on China Olmesartan Market, 2010-2019" ... olmesartan medoxomil was successfully developed by Sankyo Pharmaceuticals Co., ... 2002, olmesartan medoxomil was approved by FDA to enter ... the best- selling drug in the world after it ...
(Date:9/3/2015)... , Sept. 3, 2015 Research and ... of the "Investigation Report on China Tamsulosin ... Compared with other a1- adrenergic receptor ... selectivity and lower risk of urinary tract infections ... since its debut in 1993 in ...
Breaking Medicine Technology:IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 2IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 3China Olmesartan Investigation Market Report 2010-2019 2China Tamsulosin Market Investigation Report 2015 2
... , MOUNTAIN VIEW, Calif. , Jan. ... of a Phase I clinical trial of CCX168, an ... is a highly potent and very selective compound that ... the body,s complement system and a potent driver of ...
... , EXTON, Pa. , Jan. 28 ... medical technology company that provides innovative solutions and technologies for a ... three and six months ended December 31, 2009 . All ... to those provided in the Company,s January 15, 2010 ...
Cached Medicine Technology:ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases 2ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases 3ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases 4Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 2Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 3Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 4Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 5Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 6Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 7Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 8Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 9Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 10Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 11Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 12Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 13Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 14Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 15Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 16Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 17Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 18Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 19Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 20
... The Stryker Threaded ... surgeon yet another choice ... tunnel. Dilators provide compaction ... The compaction of bone ...
... Stryker Conquest Suture Retrievers ... that pierce through soft ... through the tissue to ... Conquest Retrievers are front ...
... The Arthroscopy Scissor is ideal for excising ... tissue debris in the joint. The serrated edge ... as well as hold tissue within the jaws ... left and right jaw curvatures, are the perfect ...
... offers state-of-the-art quality in an instrument of ... durability. Low profile cutting tips allow access ... I instruments are available in just about ... required for large and small joint arthroscopic ...
Medicine Products: